BioStockInfo · catalyst calendar
/
← Catalyst calendar

AMGN biotech catalysts & pipeline

AMGEN INC · Data as of 2026-09-08

Upcoming catalysts

dazodalibep — Full data

H2 2026

Completion of both studies is expected in H2 2026.
Source filing

TEPEZZA (teprotumumab-trbw) — Topline data

H2 2026

Study completion is expected in H2 2026.
Source filing

TEZSPIRE (tezepelumab-ekko) — Full data

H2 2026

Study completion is expected in H2 2026.
Source filing

Explore the free biotech catalyst calendar